Key Insights

Highlights

Treatment Research

2 treatments under study, led by Florbetaben 18f

Related Conditions

Often studied with 16 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
SYF1b813f52676b4e8c82d2b62df97fffd8Phase 4Recruiting

Patient- and care-related benefits of amyloid PET imaging (ENABLE)

Showing all 1 trials

Research Network

Common Treatments

  • Florbetaben 18f1
  • Flutemetamol 18f1

Active Sponsors

  • Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V.1

Related Conditions

  • Dementia In Creutzfeldtjakob Disease1
  • Dementia In Huntington Disease1
  • Subcortical Vascular Dementia1
  • Dementia In Human Immunodeficiency Virus Hiv Disease1
  • Dementia In Other Specified Diseases Classified Elsewhere1

Activity Timeline